ASRM Scientific Congress & Expo 2021, Maryland, United States Of America, 24 - 27 October 2021, vol.116, no.3, pp.28-29
Poor ovarian response (POR) accounts for approximately 15% of in vitro fertilization (IVF) cycles performed in the United States and is associated with increased rate of cycle cancellation, lower number of embryos available for transfer, and overall lower pregnancy rates. Platelet-rich plasma (PRP) is rich in growth factors and cytokines and has been used as an agent that induces tissue regeneration. PRP also promotes follicle development in vitro and has been utilized in small case series as a potential treatment for women with POR. The aim of the current study was to characterize ovarian reserve parameters and IVF outcomes in a large cohort women with poor ovarian response (POR) treated with intraovarian injection of autologous PRP.